Answers are grounded in this paper and cite their sources.
Retrospective cohort analysis found SPEP and IFE showed better correlation with MRD detection in multiple myeloma, suggesting utility in resource-limited settings.
Introduction/Objective Patients with multiple myeloma undergoing therapy require various diagnostic evaluations to assess disease response. Minimal residual disease (MRD) flow cytometry and ClonoSEQ, though highly sensitive for MRD detection, are often unavailable in resource-poor settings. This study compares the effectiveness of bone marrow analysis and other ancillary tests against ClonoSEQ in detecting MRD. Methods/Case Report A retrospective cohort of 212 multiple myeloma patients was reviewed for ClonoSEQ results alongside serum protein electrophoresis (SPEP), immunofixation electrophoresis (IFE), bone marrow biopsy with IHC, routine flow cytometry (50,000 events), and fluorescence in situ hybridization (FISH). MRD flow cytometry was not performed. Results SPEP and IFE showed greater sensitivity (52% and 64%, respectively) and better correlation with ClonoSEQ than routine flow cytometry (16%), bone marrow biopsy with IHC (24%), and FISH (17%). Ten ClonoSEQ-negative cases exhibited persistent positive bands on SPEP and IFE, aiding MRD detection. Conclusion Cost-effective and less invasive SPEP and IFE were more effective than other bone marrow studies in detecting MRD. They occasionally detected MRD cases missed by ClonoSEQ, underscoring their significance. Given the low utility of FISH, it may be omitted when plasma cells are not distinctly increased on aspirate evaluation. Routine flow cytometry does not enhance MRD detection beyond bone marrow IHC.
No takes yet. Share an insight, caveat, or question.
Jayakumar et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: